Product code OYV— Immunology

AmplideX Fragile X Dx & Carrier Screen Kit

Classification name
Inherited Nucleotide Repeat Disorder Dna Test
Device class
Class 2
Regulation
21 CFR 866.5970
Advisory panel
Immunology
Total cleared
1
First cleared
Most recent

FDA classification definition

“An inherited nucleotide repeat disorder DNA test is a prescription in vitro diagnostic test that is intended to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens. It is solely intended as an aid for carrier testing and as an aid for the diagnosis of inherited nucleotide repeat-associated disorders. Assay results are solely intended to be used in conjunction with other clinical and diagnostic findings. These tests do not include those indicated for use for fetal diagnostic testing or newborn screening.”

— U.S. Food and Drug Administration, device classification record for product code OYV under 21 CFR 866.5970, via openFDA

Market context for product code OYV

FDA has cleared 1 device under product code OYV, all in 2020, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code OYV

Recent clearances under product code OYV

Data sourced from openFDA. This site is unofficial and independent of the FDA.